12,187 Shares in Apollo Endosurgery, Inc. (NASDAQ:APEN) Acquired by Walleye Capital LLC

Walleye Capital LLC bought a new stake in Apollo Endosurgery, Inc. (NASDAQ:APENGet Rating) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 12,187 shares of the biotechnology company’s stock, valued at approximately $44,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. OLD Mission Capital LLC purchased a new stake in shares of Apollo Endosurgery in the 2nd quarter valued at $65,000. Gagnon Securities LLC increased its stake in Apollo Endosurgery by 17.4% during the second quarter. Gagnon Securities LLC now owns 1,796,500 shares of the biotechnology company’s stock worth $6,557,000 after purchasing an additional 266,588 shares during the period. Silverarc Capital Management LLC lifted its position in shares of Apollo Endosurgery by 7.0% during the second quarter. Silverarc Capital Management LLC now owns 1,074,879 shares of the biotechnology company’s stock worth $3,923,000 after purchasing an additional 70,480 shares in the last quarter. Morris Financial Concepts Inc. purchased a new position in shares of Apollo Endosurgery in the second quarter valued at approximately $41,000. Finally, Bank of America Corp DE grew its holdings in shares of Apollo Endosurgery by 542.8% in the first quarter. Bank of America Corp DE now owns 31,350 shares of the biotechnology company’s stock valued at $190,000 after purchasing an additional 26,473 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Apollo Endosurgery Price Performance

Shares of APEN opened at $5.96 on Tuesday. The company has a market cap of $248.14 million, a P/E ratio of -5.84 and a beta of 2.28. Apollo Endosurgery, Inc. has a fifty-two week low of $3.49 and a fifty-two week high of $9.11. The company has a quick ratio of 4.98, a current ratio of 6.00 and a debt-to-equity ratio of 1.26. The firm’s 50 day moving average price is $5.85 and its 200 day moving average price is $5.25.

Apollo Endosurgery Profile

(Get Rating)

Apollo Endosurgery, Inc, a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope.

Read More

Institutional Ownership by Quarter for Apollo Endosurgery (NASDAQ:APEN)

Receive News & Ratings for Apollo Endosurgery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Endosurgery and related companies with MarketBeat.com's FREE daily email newsletter.